Related Experiment Videos
[Treatment of Streptococcus pneumoiae meningitis in infants]
E Bingen1, R Cohen, A Bourrillon
1Laboratoire de microbiologie, hôpital Robert-Debré, Paris, France.
Abstract:
Due to a worldwide increasing number of cephalosporin resistant Streptococcus (S) pneumoniae strains, it appears necessary to modify the current treatment of pneumococcal meningitis. The authors recommend an initial antimicrobial regimen associating cefotaxime or ceftriaxone to vancomycin in any case of bacterial meningitis in which S pneumoniae appears to be involved (Gram positive cocci on direct examination of the CSF and/or presence of soluble bacterial antigen). There is also a need for a reappraisal of the duration of the treatment which, in any case, should not be shorter than 10 days. In the case of meningitis due to a penicillin resistant S pneumoniae, lumbar puncture must be repeated until sterilisation of the CSF.
Insights
Due to rising cephalosporin resistance in Streptococcus pneumoniae, current bacterial meningitis treatments need updates. Experts recommend combining cefotaxime/ceftriaxone with vancomycin and a minimum 10-day treatment duration for S. pneumoniae meningitis.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Context:
- Increasing global prevalence of cephalosporin-resistant Streptococcus pneumoniae strains.
- Emergence of antibiotic resistance necessitates revised treatment protocols for bacterial meningitis.
- Streptococcus pneumoniae is a leading cause of bacterial meningitis.
Purpose:
- To recommend updated treatment guidelines for bacterial meningitis caused by Streptococcus pneumoniae.
- To address the challenge of cephalosporin resistance in Streptococcus pneumoniae.
- To guide clinicians on initial antimicrobial regimens and treatment duration.
Summary:
- The study recommends an initial antimicrobial regimen of cefotaxime or ceftriaxone combined with vancomycin for bacterial meningitis involving Streptococcus pneumoniae.
- This combined therapy is advised when Gram-positive cocci are observed in cerebrospinal fluid (CSF) or soluble bacterial antigens are present.
- A treatment duration of no less than 10 days is emphasized, with repeated lumbar punctures required until CSF sterilization in cases of penicillin-resistant S. pneumoniae.
Impact:
- Provides evidence-based recommendations for managing pneumococcal meningitis in the era of antibiotic resistance.
- Aims to improve patient outcomes by ensuring effective antimicrobial therapy.
- Highlights the importance of monitoring treatment response through CSF analysis.